Su-Yeon Yu

Trends in incidence and medical costs of human papillomavirus-related diseases in Korea: evidence from National Health Insurance claims.

These descriptive findings provide population-level evidence on HPV-associated disease burden in Korea but cannot establish causal attribution to vaccination, screening or other preventive interventions, necessitating continued surveillance with individual-level data linkage.